HK$11.13
0.54%
Hong Kong, Mon, Sep 21 2026.
ISIN
KYG211081248
Symbol
867

China Medical System Holding Stock price

HK$11.13
-0.44 3.80% 1M
-1.95 14.91% 6M
-1.77 13.72% YTD
-3.69 24.90% 1Y
-0.27 2.37% 3Y
-3.55 24.18% 5Y
-2.67 19.35% 10Y
+8.12 270.01% 20Y
Hong Kong, Closing price Mon, Sep 21 2026
+0.06 0.54%
ISIN
KYG211081248
Symbol
867
Industry

Is China Medical System Holding a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,133 stocks worldwide.

Key metrics

Basic
Market capitalization
HK$27.0b
Enterprise Value
HK$21.3b
Net debt
positive
Cash
HK$6.7b
Shares outstanding
2.4b
Valuation (TTM | estimate)
P/E
15.0
P/S
2.6 | 2.3
EV/Sales
2.1 | 1.8
EV/FCF
-
P/B
1.3
Dividends
DPS
HK$0.34
Yield 1Y | 5Y
3.1% | 3.8%
Growth 1Y | 5Y
15.4% | -9.3%
Payout 1Y | 3Y
41.4% | 43.9%
Increased
2 Years
Financials (TTM | estimate)
Revenue
HK$10.2b | HK$11.5b
EBITDA
-
EBIT
HK$2.3b
Net Income
HK$1.8b
Free Cash Flow
-
Growth (TTM | estimate)
Revenue
10.8% | 19.5%
EBITDA
-
EBIT
9.9%
Net Income
-7.1%
Free Cash Flow
-
Margin
Gross
71.2%
EBITDA
-
EBIT
22.1%
Net
17.6%
Free Cash Flow
-
Financial Health
Equity Ratio
90.6%
Return on Equity
8.6%
ROCE
10.5%
ROIC
9.8%
Debt/Equity
0.0
More
EPS
HK$0.7
FCF per Share
-
Short interest
-
Employees
6k
Rev per Employee
HK$1.5m

China Medical System Holding Stock Analysis

Unlock Scores for Free

Analyst Opinions

14 Analysts have issued a China Medical System Holding forecast:

12x Buy
86%
2x Hold
14%

Analyst Opinions

14 Analysts have issued a China Medical System Holding forecast:

Buy
86%
Hold
14%

Financial data from China Medical System Holding

Jun '26
+/-
%
10,206 10,206
11% 11%
100%
- Direct Costs 2,942 2,942
12% 12%
29%
7,264 7,264
10% 10%
71%
- Selling and Administrative Expenses 4,363 4,363
5% 5%
43%
- Research and Development Expense 866 866
73% 73%
8%
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 2,253 2,253
10% 10%
22%
Net Profit 1,797 1,797
7% 7%
18%

In millions HKD.

Don't miss a Thing! We will send you all news about China Medical System Holding directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

China Medical System Holding Stock News

Neutral
GlobeNewsWire
19 days ago
SHENZHEN, CHINA, Sept. 03, 2026 (GLOBE NEWSWIRE) -- China Medical System Holdings Limited (“CMS” or the “Group”) is pleased to announce that its subsidiary, Dermavon Holdings Limited (“Dermavon”, an innovative pharmaceutical company specialized in skin health which is applying for a separate listing on the Main Board of The Stock Exchange of Hong Kong Limited) received the approval from the Nat...

Company Profile

China Medical System Holdings Ltd. engages in the production, marketing, promotion, and sale of drugs. The company employs 6,415 full-time employees The company went IPO on 2010-09-28. The firm's products include Plendil, Ursofalk, Augentropfen Stulln Mono Eye Drops, Hirudoid, Atopic Piel Series and Vmonalisa, among others. Its major marketed products cover the cardio-cerebrovascular, gastroenterology, ophthalmology, dermatology and medical aesthetic fields. The firm distributes its products within domestic market and to overseas markets.

Head office Cayman Islands
CEO Mr. Lam
Employees 6,415
Website web.cms.net.cn

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today